ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 165 filers reported holding ACORDA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $25,000 | -93.2% | 26,561 | -85.3% | 0.00% | -100.0% |
| Q4 2019 | $368,000 | +30.0% | 180,315 | +82.7% | 0.00% | 0.0% |
| Q3 2019 | $283,000 | -40.3% | 98,676 | +59.6% | 0.00% | 0.0% |
| Q2 2019 | $474,000 | -21.4% | 61,833 | +36.3% | 0.00% | 0.0% |
| Q1 2019 | $603,000 | +2.9% | 45,356 | +20.5% | 0.00% | 0.0% |
| Q4 2018 | $586,000 | -19.9% | 37,639 | +1.1% | 0.00% | -50.0% |
| Q3 2018 | $732,000 | -31.5% | 37,243 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,069,000 | +17.5% | 37,243 | -3.2% | 0.00% | 0.0% |
| Q1 2018 | $910,000 | +7.7% | 38,492 | -2.3% | 0.00% | 0.0% |
| Q4 2017 | $845,000 | -10.5% | 39,380 | -1.4% | 0.00% | 0.0% |
| Q3 2017 | $944,000 | +132.5% | 39,931 | +93.5% | 0.00% | +100.0% |
| Q2 2017 | $406,000 | +3.3% | 20,633 | +10.1% | 0.00% | 0.0% |
| Q1 2017 | $393,000 | +11.6% | 18,736 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $352,000 | -15.8% | 18,736 | -6.4% | 0.00% | 0.0% |
| Q3 2016 | $418,000 | -20.8% | 20,018 | -3.3% | 0.00% | 0.0% |
| Q2 2016 | $528,000 | -86.7% | 20,702 | -86.2% | 0.00% | -90.0% |
| Q1 2016 | $3,956,000 | -59.2% | 149,575 | -33.9% | 0.01% | -58.3% |
| Q4 2015 | $9,685,000 | +7.2% | 226,378 | -33.6% | 0.02% | +4.3% |
| Q3 2015 | $9,035,000 | -58.0% | 340,812 | -47.3% | 0.02% | -53.1% |
| Q2 2015 | $21,534,000 | +2.2% | 646,092 | +2.0% | 0.05% | +4.3% |
| Q1 2015 | $21,079,000 | -8.0% | 633,387 | +13.0% | 0.05% | -7.8% |
| Q4 2014 | $22,901,000 | +23.3% | 560,312 | +2.2% | 0.05% | +21.4% |
| Q3 2014 | $18,570,000 | -3.9% | 548,112 | -4.4% | 0.04% | -4.5% |
| Q2 2014 | $19,322,000 | -17.9% | 573,212 | -7.7% | 0.04% | -18.5% |
| Q1 2014 | $23,549,000 | +37.0% | 621,201 | +5.5% | 0.05% | +35.0% |
| Q4 2013 | $17,190,000 | +7.5% | 588,701 | +26.2% | 0.04% | 0.0% |
| Q3 2013 | $15,992,000 | +15.3% | 466,506 | +10.9% | 0.04% | +5.3% |
| Q2 2013 | $13,871,000 | – | 420,475 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 7,106,955 | $139,652,000 | 2.69% |
| Malaga Cove Capital, LLC | 52,987 | $1,035,000 | 0.56% |
| PFM Health Sciences, LP | 1,699,100 | $33,387,000 | 0.49% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 75,000 | $1,474,000 | 0.43% |
| Spark Investment Management LLC | 320,400 | $6,295,000 | 0.36% |
| PFM Health Sciences, LP | 1,247,434 | $24,512,000 | 0.36% |
| Partner Investment Management, L.P. | 20,900 | $411,000 | 0.32% |
| Kazazian Asset Management, LLC | 14,454 | $284,000 | 0.27% |
| DLD Asset Management, LP | 271,500 | $5,327,000 | 0.26% |
| Partner Investment Management, L.P. | 15,516 | $305,000 | 0.23% |